文献速递治疗药物监测与药物基因组学

基于模型指导的利福平个体化给药用于结核病治疗

Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin.
PubMed 文献 · Clin Pharmacokinet · 2019-01-01

本研究利用两个肺结核患者数据集评估九种利福平群体药代动力学模型,发现Svensson等模型最适用,采用2小时和4小时采血结合模型预测AUC24和Cmax,与线性回归TDM策略性能相当但偏倚更小,可缩短采样时间并减少采样点。

要点

  • 2小时和4小时双点采血结合模型预测可替代线性回归TDM策略。
  • 模型法预测AUC24的偏倚为1.5%,低于线性回归的9.9%。
  • 该方法已成功整合入InsightRX精准给药平台。

核心结论

  • 2小时和4小时采血结合模型预测可用于替代现行线性回归TDM策略,缩短采样2小时并减少一个采样点且不损失性能。

研究设计与样本

  • 使用两个肺结核患者数据集:药代动力学研究34例患者373个样本,TDM数据96例患者391个样本,均来自荷兰Radboud大学医学中心。
  • 从文献中识别九种利福平群体药代动力学模型并在数据集上评估,基于图形拟合优度、残差诊断和预测性能选择最适模型。

主要发现

  • Svensson等开发的模型基于图形拟合优度、残差诊断和预测性能被评为最适用。
  • 2小时和4小时采血策略被选为最适采样策略。
  • 模型法与线性回归法在预测AUC24和Cmax的偏倚和精度上相当,但线性回归法预测AUC24偏倚更大(ME分别为9.9%和1.5%)。
  • 基于模拟数据集的剂量建议比较显示两种方法在敏感性和特异性上无显著差异。

关键数值与推荐

  • 模型法预测AUC24的ME为1.5%,线性回归法ME为9.9%。

临床怎么用

  • 临床可采用2小时和4小时双点采血结合模型预测进行利福平TDM,替代线性回归策略以缩短采样时间并增加采样灵活性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: This study proposes a model-informed approach for therapeutic drug monitoring (TDM) of rifampicin to improve tuberculosis (TB) treatment. METHODS: Two datasets from pulmonary TB patients were used: a pharmacokinetic study (34 patients, 373 samples), and TDM data (96 patients, 391 samples) collected at Radboud University Medical Center, The Netherlands. Nine suitable population pharmacokinetic models of rifampicin were identified in the literature and evaluated on the datasets. A model developed by Svensson et al. was found to be the most suitable based on graphical goodness of fit, residual diagnostics, and predictive performance. Prediction of individual area under the concentration-time curve from time zero to 24 h (AUC24) and maximum concentration (Cmax) employing various sampling strategies was compared with a previously established linear regression TDM strategy, using sampling at 2, 4, and 6 h, in terms of bias and precision (mean error [ME] and root mean square error [RMSE]). RESULTS: A sampling strategy using 2- and 4-h blood collection was selected to be the most suitable. The bias and precision of the two strategies were comparable, except that the linear regression strategy was more biased in prediction of the AUC24 than the model-informed approach (ME of 9.9% and 1.5%, respectively). A comparison of resulting dose advice, using predictions on a simulated dataset, showed no significant difference in sensitivity or specificity between the two methods. The model was successfully implemented in the InsightRX precision dosing platform. CONCLUSION: Blood sampling at 2 and 4 h, combined with model-based prediction, can be used instead of the currently used linear regression strategy, shortening the sampling by 2 h and one sampling point without performance loss while simultaneously offering flexibility in sampling times.

来源:Clin Pharmacokinet,查看原文。版权归原作者所有。

引用

  1. van Beek SW, Ter Heine R, Keizer RJ, et al. Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin. Clin Pharmacokinet. 2019. PMID: 30671890. doi:10.1007/s40262-018-00732-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。